Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine
- 23 April 2009
- Vol. 27 (28) , 3766-3774
- https://doi.org/10.1016/j.vaccine.2009.03.090
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Intradermal NKT cell activation during DNA priming in heterologous prime‐boost vaccination enhances T cell responses and protection against LeishmaniaEuropean Journal of Immunology, 2008
- Functional Genomic and Serological Analysis of the Protective Immune Response Resulting from Vaccination of Macaques with an NS1-Truncated Influenza VirusJournal of Virology, 2007
- Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swineVaccine, 2007
- The perfect mix: recent progress in adjuvant researchNature Reviews Microbiology, 2007
- Live‐attenuated influenza viruses as delivery vectors for Chlamydia vaccinesImmunology, 2007
- Invariant NKT cells sustain specific B cell responses and memoryProceedings of the National Academy of Sciences, 2007
- Inhibition of Retinoic Acid-Inducible Gene I-Mediated Induction of Beta Interferon by the NS1 Protein of Influenza A VirusJournal of Virology, 2007
- Vaccination of Pigs against Swine Influenza Viruses by Using an NS1-Truncated Modified Live-Virus VaccineJournal of Virology, 2006
- Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of miceProceedings of the National Academy of Sciences, 2006
- Influenza Virus Evades Innate and Adaptive Immunity via the NS1 ProteinJournal of Virology, 2006